| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/05/2012 | CA2803983A1 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | CA2803980A1 Coated effervescent tablet |
| 01/05/2012 | CA2803721A1 Pharmaceutical composition comprising drospirenone and contraceptive kit |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803377A1 Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 01/05/2012 | CA2803257A1 Injectable pharmaceutical compositions for the treatment of joints |
| 01/05/2012 | CA2803010A1 Dissolvable fibrous web structure article comprising active agents |
| 01/05/2012 | CA2802816A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | CA2802606A1 Formulations and delivery |
| 01/05/2012 | CA2802303A1 Pharmaceutical compositions comprising paracetamol and process for preparing the same |
| 01/05/2012 | CA2801826A1 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate |
| 01/05/2012 | CA2801466A1 Use of squaramide in the prevention and/or treatment of rosacea |
| 01/05/2012 | CA2799587A1 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | CA2798028A1 Liquid formulations of rupatadine fumarate |
| 01/05/2012 | CA2793502A1 Desmopressin for reducing nocturnal voids |
| 01/04/2012 | EP2402387A1 Use of an article based on a polymeric composition |
| 01/04/2012 | EP2402342A1 Pharmaceutical composition for treatment of 2 type dabetes |
| 01/04/2012 | EP2402075A1 Method and device for producing vesicles |
| 01/04/2012 | EP2402035A1 Coating material for solid medicine and solid medicine formed with same |
| 01/04/2012 | EP2402018A1 Magnesium oxide fine granules |
| 01/04/2012 | EP2402012A2 Liquid formulations of rupatadine fumarate |
| 01/04/2012 | EP2402010A1 Solid drug for oral use |
| 01/04/2012 | EP2402008A1 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 01/04/2012 | EP2402007A1 Coenzyme q10-containing composition for oral ingestion |
| 01/04/2012 | EP2402006A1 Bandseal for peg-filled hard capsule |
| 01/04/2012 | EP2402005A1 Sustained release formulations of nalbuphine |
| 01/04/2012 | EP2402004A2 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 01/04/2012 | EP2402003A2 Diclofenac formulations and methods of use |
| 01/04/2012 | EP2402002A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/04/2012 | EP2402001A1 Formulations for alteration of biophysical properties of mucosal lining |
| 01/04/2012 | EP2401914A1 Antiseptic based on bispyridinium alkanes |
| 01/04/2012 | EP2401262A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401024A2 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| 01/04/2012 | EP2400988A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 01/04/2012 | EP2400980A2 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 01/04/2012 | EP2400974A2 Synthetic diblock copolypeptide hydrogels for use in the central nervous system |
| 01/04/2012 | EP2400958A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa |
| 01/04/2012 | EP2400957A2 A controlled release micro-capsule for osteogenic action |
| 01/04/2012 | EP2400956A1 Phospholipid and protein tablets |
| 01/04/2012 | EP2400955A1 Methods of administering (4ar, 1oar)-i-n-propyl-i, 2,3,4a7 s1io7 ioa-octahydrobenzo ýg¨quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof |
| 01/04/2012 | EP2400954A2 Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts |
| 01/04/2012 | EP2400953A1 Uses of nk receptor antagonists |
| 01/04/2012 | EP2400952A2 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof |
| 01/04/2012 | EP2400951A1 Topical foam composition |
| 01/04/2012 | EP2400950A1 Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol |
| 01/04/2012 | EP2400851A1 Composition and drug delivery of bisphosphonates |
| 01/04/2012 | EP2400842A1 Otic compositions useful for the treatment of infections of the internal and external ear in mammals |
| 01/04/2012 | EP2400838A1 Narcotic emulsion formulations for treatment of cancer pain |
| 01/04/2012 | EP2259801B1 Stable pharmaceutical compositions of carvedilol |
| 01/04/2012 | EP2182923B1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 01/04/2012 | EP2104695B1 Adhesive-forming composition and blend of adhesives obtained therefrom |
| 01/04/2012 | EP2047857B1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/04/2012 | EP1888048B1 Method for handling adhesive laminate sections |
| 01/04/2012 | EP1671635B1 Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 01/04/2012 | EP1620058B1 Composition for improving cognition and memory |
| 01/04/2012 | EP1494649B1 Nanoparticulate megestrol formulations |
| 01/04/2012 | EP1465688B1 Bicarbonate-based solutions for dialysis therapies |
| 01/04/2012 | CN202096485U Long-acting drug patch |
| 01/04/2012 | CN1997446B Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them |
| 01/04/2012 | CN1954855B Eye preparation containing sodium hyaluronate for treating fundus macular degeneration and its preparation method |
| 01/04/2012 | CN1449746B Soft capsule containing trace element |
| 01/04/2012 | CN102307598A Pharmaceutical compositions comprising TGF-beta1 inhibitor peptides |
| 01/04/2012 | CN102307597A Controlled-release composition for producing sustained-release preparation containing udenafil |
| 01/04/2012 | CN102307576A Methods for enhancing the release and absorption of water insoluble active agents |
| 01/04/2012 | CN102307575A Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process |
| 01/04/2012 | CN102307574A Sustained release drug delivery system |
| 01/04/2012 | CN102307573A Tablets for combination therapy |
| 01/04/2012 | CN102307572A Novel composition for treatment of essential thrombocythemia |
| 01/04/2012 | CN102307571A Clostridial toxin pharmaceutical compositions |
| 01/04/2012 | CN102307570A Porous structures with modified biodegradation kinetics |
| 01/04/2012 | CN102307569A Pharmaceutical compositions comprising imidazoquinolin (amines) and derivatives thereof suitable for local administration |
| 01/04/2012 | CN102307568A Resvertrol compositions |
| 01/04/2012 | CN102307567A Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
| 01/04/2012 | CN102307557A Method for producing liposomal drugs and a device for producing a liposome |
| 01/04/2012 | CN102304570A Compositions and methods for cancer diagnosis and therapy |
| 01/04/2012 | CN102304483A Enterococcus faecium for feeding and applications thereof |
| 01/04/2012 | CN102304225A Polymer liposomes based on polyamino acid and quaternary ammonium salt and preparation method for polymer liposomes |
| 01/04/2012 | CN102304150A Phospho-indoles as HIV inhibitors |
| 01/04/2012 | CN102304112A Vesicle with two-photon excitation controlled-release function, and preparation method and application thereof |
| 01/04/2012 | CN102304107A Method for preparing ranitidine carboxylic acid bismuth |
| 01/04/2012 | CN102302779A Cream preparation used for treating phimosis, and application thereof |
| 01/04/2012 | CN102302778A Preparation method and application of traditional Chinese medicinal immunoglobulin compound preparation |
| 01/04/2012 | CN102302768A Method for preparing brain protein hydrolysate oral liquid |
| 01/04/2012 | CN102302766A Capsules for treating stomach disease |
| 01/04/2012 | CN102302765A Herba sarcandrae, rhizoma cibotii, suberect spatholobus stem and muskroot-like semiaquilegia root powder for treating lower extremity varicose veins |
| 01/04/2012 | CN102302756A Foot bath Chinese medicinal composition for treating cough |
| 01/04/2012 | CN102302752A Traumatic injury plaster |
| 01/04/2012 | CN102302747A Production formula and preparation method of quick-acting chilblain ointment |
| 01/04/2012 | CN102302732A Liver-soothing and blood-stasis-removing granules and preparation method thereof |
| 01/04/2012 | CN102302714A Traditional Chinese medicine for treating primary lung cancer |
| 01/04/2012 | CN102302704A Preparation method for toxin expelling and verruca dispelling pill |
| 01/04/2012 | CN102302701A Orally disintegrating tablets for treating functional dyspepsia |
| 01/04/2012 | CN102302687A Chinese medicinal powder for preventing and controlling common disease of livestock and poultry |
| 01/04/2012 | CN102302684A Radix notoginseng tablets for promoting blood circulation |
| 01/04/2012 | CN102302677A Burn and scald liquid, burn and scald ointment, and preparation method thereof |
| 01/04/2012 | CN102302672A Honeysuckle flower buccal tablets and preparation method thereof |
| 01/04/2012 | CN102302660A Traditional Chinese medicine aerosol used for treating chronic bronchitis |
| 01/04/2012 | CN102302652A Capsules for clearing away heat and toxic materials |
| 01/04/2012 | CN102302645A Oral liquid for treating hypertensive cardio-cerebrovascular syndrome |
| 01/04/2012 | CN102302643A Medicine for treating functional uterine bleeding |